TITLE

Esomeprazole 40mg once daily and lansoprazole 30mg twice daily for heartburn symptoms in patients with resistant GERD

AUTHOR(S)
Fass, Ronnie; Traxler, Barry M; Thomas, Samisha; Sostek, Mark B
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS35
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Esomeprazole 40mg Once Daily and Lansoprazole 30mg Twice Daily for Heartburn Symptoms in Patients with Resistant GERD," by Ronnie Fass, Barry M. Traxler, Samisha Thomas, and Mark B Sostek is presented.
ACCESSION #
66954593

 

Related Articles

  • Once-daily esomeprazole and twice-daily lansoprazole in controlling epigastric pain and acid regurgitation in patients with resistant GERD. Fass, Ronnie; Traxler, Barry M; Thomas, Samisha; Sostek, Mark B // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS38 

    An abstract of the article "Once-daily Esomeprazole and Twice-daily Lansoprazole in Controlling Epigastric Pain and Acid Regurgitation in Patients with Resistant GERD," by Ronnie Fass, Barry M. Traxler, Samisha Thomas, and Mark B. Sostek is presented.

  • Esomeprazole a cost-effective cure for reflux oesophagitis.  // PharmacoEconomics & Outcomes News;12/17/2005, Issue 493, p5 

    The article focuses on a study presented at the 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research in Florence, Italy in November 2005, which revealed that esomeprazole is a cost-effective cure for reflux oesophagitis. It discusses a...

  • Esomeprazole of value for persistent GERD in Canada.  // PharmacoEconomics & Outcomes News;10/30/2010, Issue 615, p6 

    The article discusses research on the cost effectiveness of esomeprazole to treat gastroesophageal reflux disease (GERD) in Canada, which references the study "The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care:...

  • Supplementation of Los Angeles classification with esophageal mucosa index of hemoglobin can predict the treatment response of erosive reflux esophagitis. Hsin Cheng; Yu-Ching Tsai; Wei-Ying Chen; Wei-Lun Chang; Hsiu-Chi Cheng; Bor-Shyang Sheu // Surgical Endoscopy;Aug2011, Vol. 25 Issue 8, p2478 

    Background: We assessed whether the esophageal mucosa index of hemoglobin (IHb) could assist the Los Angeles (LA) classification in defining the severity of erosive reflux esophagitis (RE) and predicting the treatment response by esomeprazole. Methods: Five hundred twenty-four subjects (424 RE...

  • Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience. Attwood, S. E.; Lundell, L.; Hatlebakk, J. G.; Eklund, S.; Junghard, O.; Galmiche, J.-P.; Ell, C.; Fiocca, R.; Lind, T. // Journal of Gastrointestinal Surgery;Oct2008, Vol. 12 Issue 10, p1646 

    Introduction: The long-term management of gastroesophageal reflux in patients with Barrett's esophagus (BE) is not well supported by an evidence-based consensus. We compare treatment outcome in patients with and without BE submitted to standardized laparoscopic antireflux surgery...

  • esomeprazole.  // Davis's Drug Guide for Nurses, 10th edition;2007, p479 

    The article presents a nursing guide to esomeprazole, an antiulcer agent for the treatment of GERD, including erosive esophagitis, among others. Its mechanism of action and pharmacokinetics are explained. Contraindications for the drug are presented. Its adverse reactions are cited. Nursing...

  • Esomeprazole Versus Pantoprazole for Healing Erosive Oesophagitis. Včev, Aleksandar; Begić, Ivana; Ostojić, Rajko; Jurčić, Dragan; Božić, Dubravko; Soldo, Ivan; Gmajnić, Rudika; Kondža, Goran; Khaznadar, Eyad; Mićunović, Nikola // Collegium Antropologicum;Sep2006, Vol. 30 Issue 3, p519 

    The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to healing and relief from gastroesophageal reflux disease-related symptoms. I this multicentre, randomized, single-blind study 180 patients (ITT population) diagnosed with endoscopically proven GERD...

  • Esomeprazole.  // Reactions Weekly;11/28/2009, Issue 1280, p22 

    The article describes the case of a 64-year-old man who developed elevated human chromogranin A (CgA) levels after receiving esomeprazole for gastro-esophageal reflux. The patient was evaluated for an adrenal tumor in April 2004. Histopathological findings on the patient revealed adenoma with...

  • Pantoprazole On-Demand Effectively Treats Symptoms in Patients with Gastro-Oesophageal Reflux Disease. Scholten, Theo; Teutsch, Iris; Bohuschke, Martina; Gatz, Gudrun // Clinical Drug Investigation;2007, Vol. 27 Issue 4, p287 

    Objective: The efficacy of pantoprazole as on-demand therapy for the long-term management of patients with mild gastro-oesophageal reflux disease (GORD) has been demonstrated in clinical studies. In this study, the efficacy of pantoprazole 20mg and esomeprazole 20mg as on-demand therapy for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics